Skip to content


NeoVentures is thrilled to introduce Neomers, our novel method of aptamer selection. Explore what makes Neomers unique now, or get in touch with our team to find out how it can specifically benefit your business.

What Makes Neomers Different?

B-cells can produce antibodies that are less likely to self-bind than aptamers

Immune Tolerance

Unlike with SELEX, the Neomer platform mimics natural immune tolerance, allowing us to eliminate self-binding. Learn more about what this means, how it works and why it matters for your next project.

Pages of a licensing contract with a pen sitting on top

Licensing Opportunities

We have decided to make the Neomer library available for licensing to labs that have the capacity for selection in-house. This route offers substantial savings over our traditional custom aptamer design. Find out more about licensing.

Learn more about the unique opportunities for your business by speaking with our team

Read More About Neomers in Our Blog

Watch Dr. Gregory Penner's Presentation

A Reproducible Aptamer Selection Method

This conference took place on April 4th at Aptamers 2022. 

Dr. Gregory Penner introduced our game-changing new method of aptamer selection. Hear what he has to say about it by watching the full presentation.  

Fill in the form for instant access.

Get Instant Access Now